![DiscGenics](https://gocience.com/logos/new/0c59ace3cadc839f8c865658f7380188ac4e39071ec0350159f2a53dded0d205.jpg)
Disc Genics
Biotechnology, 5940 W Harold Gatty Dr, Salt Lake City, Utah, 84116, United States, 11-50 Employees
Phone Number: 80********
Who is DISCGENICS
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with ...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 5940 W Harold Gatty Dr, Salt Lake City, Utah, 84116, United States
-
Date Founded: 2007
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from DISCGENICS
DiscGenics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding DiscGenics
Answer: DiscGenics's headquarters are located at 5940 W Harold Gatty Dr, Salt Lake City, Utah, 84116, United States
Answer: DiscGenics's phone number is 80********
Answer: DiscGenics's official website is https://discgenics.com
Answer: DiscGenics's revenue is $1 Million to $5 Million
Answer: DiscGenics's SIC: 8731
Answer: DiscGenics's NAICS: 541714
Answer: DiscGenics has 11-50 employees
Answer: DiscGenics is in Biotechnology
Answer: DiscGenics contact info: Phone number: 80******** Website: https://discgenics.com
Answer: DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we hope will be a profound therapeutic option for millions of patients suffering from the debilitating effects of back pain. DiscGenics first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month